Health and Wellness

Bridging the Treatment Gap: Landmark SINGLE-AF Trial Validates DOAC Use for Intermediate-Risk Atrial Fibrillation

For years, the clinical management of atrial fibrillation (AF) has been bifurcated by a significant "gray area." While the medical...